Risankizumab Effective Through 100 Weeks in Improving Signs, Symptoms of Psoriatic Arthritis
These data suggest risankizumab was both safe and efficacious through 100 weeks for PsA patients, with no new safety signals.
Source: hcplive.com
Stay updated with breaking news from Week Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These data suggest risankizumab was both safe and efficacious through 100 weeks for PsA patients, with no new safety signals.
Who will remove Lukashenka?
Neuraptive Therapeutics Inc. a leader in nerve repair and regeneration is pleased to announce a significant milestone in transforming the treatment paradigm for peripheral nerve injuries.
The NEUROFUSE Study is an ongoing 48-week Multicenter, Randomized, evaluator-blinded, Phase 2a study in upper extremity nerve transections comparing NTX-001…